4.5 Article

Telomeric 3′-overhang length is associated with the size of telomeres

期刊

EXPERIMENTAL GERONTOLOGY
卷 43, 期 4, 页码 258-265

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.exger.2008.01.005

关键词

telomere; telomerase; telomeric T-overhang; senescence; hTERT-immortalized

资金

  1. Biotechnology and Biological Sciences Research Council Funding Source: Medline

向作者/读者索取更多资源

Telomeres are specialized DNA/protein complexes that cap eukaryotic chromosome ends as T-loop structures and maintain genomic integrity. Vertebrate telomeric DNA consists of tandem double-strand repeats which terminate in a 3' single-strand G-rich overhang. The telomeric 3'-overhang is important for the formation of the T-loop. In mammalian mortal somatic cells, telomeres shorten with each successive division and contribute to the onset of replicative senescence. The exact molecular mechanism underlying replicative senescence remains unclear: whether telomere shortening is the only trigger or loss of telomeric 3'-overhang plays a causal role. To further address this issue, we investigated telomeric 3'-overhang and telomere changes during cell proliferation toward replicative senescence. We demonstrate here that telomeric 3'-overhang, similar to telomeres, exhibits progressive attrition with each cell division in primary sheep fibroblasts and that telomeric 3'-overhang size does not determine the rate of telomere shortening. Furthermore, the sizes of telomeric 3'-overhangs are associated with telomere lengths. Our results suggest that alteration of the 3'-overhang and the telomere during cellular proliferation are associated. Together they may contribute to maintain chromosomal stability and to regulate replicative senescence. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors

Joshua Branter, Maria Estevez-Cebrero, Mohammed Diksin, Michaela Griffin, Marcos Castellanos-Uribe, Sean May, Ruman Rahman, Richard Grundy, Surajit Basu, Stuart Smith

Summary: The lack of treatment options for high-grade brain tumors has led to the exploration of alternative therapeutic modalities, including electrical field therapy. This study demonstrates the effectiveness of electric fields, delivered via TTFields or Deep Brain Stimulation (DBS), in inhibiting the viability of brain tumor cell lines. The study also uncovers potential mechanisms of action, with both treatments affecting cell cycle progression and showing interactions with mitochondrial functioning and endoplasmic reticulum stress.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Materials Science, Biomaterials

Investigating histidinylated highly branched poly(lysine) for siRNA delivery

Ali Alazzo, Nurcan Gumus, Pratik Gurnani, Snjezana Stolnik, Ruman Rahman, Keith Spriggs, Cameron Alexander

Summary: Higher molar mass derivatives of poly(lysine) were found to yield smaller polyplexes with greater affinity for siRNA and higher transfection efficiency, although they may come with some cytotoxicity. Histidinylation improved biocompatibility slightly, but did not significantly enhance gene silencing efficiency compared to non-histidinylated derivatives.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Article Biochemistry & Molecular Biology

Transcription Profile and Pathway Analysis of the Endocannabinoid Receptor Inverse Agonist AM630 in the Core and Infiltrative Boundary of Human Glioblastoma Cells

Gareth Williams, David Chambers, Ruman Rahman, Francisco Molina-Holgado

Summary: By performing a transcriptional analysis of AM630 activity in different cell lines of glioblastoma, we found significant differences in gene expression profiles between core cells and invasive margin cells. Only the core cells expressed the potential target of AM630, the CB1 receptor, while the HTR2B serotonin receptor was moderately expressed in both cell types. Additionally, the AM630-driven transcriptional response was stronger in core cells, resulting in upregulation of immune response and downregulation of cell cycle and metastatic pathways.

MOLECULES (2022)

Article Pharmacology & Pharmacy

Detection of Label-Free Drugs within Brain Tissue Using Orbitrap Secondary Ion Mass Spectrometry as a Complement to Neuro-Oncological Drug Delivery

Phoebe McCrorie, Jonathan Rowlinson, David J. Scurr, Maria Marlow, Ruman Rahman

Summary: Historically, pre-clinical neuro-oncological drug delivery studies have primarily relied on overall animal survival as a measure of efficacy. However, this study demonstrates the potential of OrbiSIMS, a next-generation analytical instrument, to accurately detect brain penetration of drug compounds and provide imaging capabilities. This method could complement in vivo efficacy studies and assess the distribution and penetration of drugs in the brain.

PHARMACEUTICS (2022)

Article Multidisciplinary Sciences

Metabolic modeling-based drug repurposing in Glioblastoma

Claudio Tomi-Andrino, Alina Pandele, Klaus Winzer, John King, Ruman Rahman, Dong-Hyun Kim

Summary: The heterogeneity of cancer hampers the development of universal cancer treatments, requiring tailored therapies for each type of cancer. Reprogramming cellular metabolism is seen as a potential source of drug targets. More strategies are needed to reduce and prioritize the list of potential candidates for drug repurposing.

SCIENTIFIC REPORTS (2022)

Article Oncology

Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism

James Wood, Salah Abdelrazig, Sergey Evseev, Catherine Ortori, Marcos Castellanos-Uribe, Sean T. May, David A. Barrett, Mohammed Diksin, Sajib Chakraborty, Dong-Hyun Kim, Richard G. Grundy, Ruman Rahman

Summary: High-grade gliomas are aggressive cancers that require cholesterol for their energy needs. The drug LXR-623 can reduce the levels of cholesterol inside cancer cells and impair their growth. This research provides evidence for using LXR-623 to test its effectiveness in increasing the survival of mice with high-grade gliomas.

CANCERS (2022)

Article Pharmacology & Pharmacy

Development of nanoparticle loaded microneedles for drug delivery to a brain tumour resection site

Paula Muresan, Phoebe McCrorie, Fiona Smith, Catherine Vasey, Vincenzo Taresco, David J. Scurr, Stefanie Kern, Stuart Smith, Pavel Gershkovich, Ruman Rahman, Maria Marlow

Summary: This study developed polymeric microneedle (MN) patches for the treatment of CNS tumors. The results demonstrated successful drug release and penetration, providing a potential solution for local brain drug delivery.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)

Review Oncology

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials

Ruman Rahman, Miroslaw Janowski, Clare L. Killick-Cole, William G. B. Singleton, Emma Campbell, Piotr Walczak, Soumen Khatua, Lukas Faltings, Marc Symons, Julia R. Schneider, Kevin Kwan, John A. Boockvar, Steven S. Gill, J. Miguel Oliveira, Kevin Beccaria, Alexandre Carpentier, Michael Canney, Monica Pearl, Gareth J. Veal, Lisethe Meijer, David A. Walker

Summary: Brain tumors are the leading cause of cancer deaths in children and young adults, but drug treatments have had limited success due to the blood-brain barrier. This review explores techniques to enhance drug delivery to brain tumors and discusses preclinical models for translational development. It also highlights the potential of existing approved drugs when combined with efficient delivery methods. This research aims to address the current challenges faced by children with brain tumors and improve treatment outcomes.

CANCERS (2023)

Article Chemistry, Analytical

Untargeted Metabolomic Characterization of Glioblastoma Intra- Tumor Heterogeneity Using OrbiSIMS

Wenshi He, Max K. Edney, Simon M. L. Paine, Rian L. Griffiths, David J. Scurr, Ruman Rahman, Dong-Hyun Kim

Summary: This study used the OrbiSIMS technique to investigate the metabolism of brain tumors within their highly heterogeneous microenvironment. The results showed that OrbiSIMS could differentiate morphologically distinct regions within single tumors. Cancer cells from necrotic regions were separated from viable GBM cells based on specific metabolites. In addition, tryptophan metabolism was discovered to be essential for GBM cellular survival. This study demonstrates the potential of OrbiSIMS for understanding tumor heterogeneity and developing targeted therapies.

ANALYTICAL CHEMISTRY (2023)

Article Nanoscience & Nanotechnology

Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain

Paula Muresan, Stephen Woodhams, Fiona Smith, Vincenzo Taresco, Jaymin Shah, Mei Wong, Victoria Chapman, Stuart Smith, Gareth Hathway, Ruman Rahman, Pavel Gershkovich, Maria Marlow

Summary: We investigated the biodistribution of cannabidiol (CBD) in the central nervous system (CNS) and found that both an oil-in-water (O/W) nanoemulsion and polymer-coated nanoparticles (PCNPs) were preferentially retained in the spinal cord, with high concentrations reaching the brain within a short time. The CBD nanoemulsion showed faster brain delivery than the CBD PCNPs, with higher retention in the brain. Both formulations exhibited immediate anti-nociceptive effects.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2023)

Article Chemistry, Multidisciplinary

Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting

Claudia Martins, Marco Araujo, Alessio Malfanti, Catarina Pacheco, Stuart J. J. Smith, Bernard Ucakar, Ruman Rahman, Jonathan W. W. Aylott, Veronique Preat, Bruno Sarmento

Summary: Report the development of hypothesis-driven stimuli-responsive nanoparticles (NPs) for glioblastoma (GBM) therapy. These NPs have multifunctional features that overcome the insufficient blood-brain barrier (BBB) trafficking and lack of GBM targeting, two major challenges in anti-GBM treatments. In preclinical studies, the stimuli-responsive NPs effectively targeted GBM cells, enhanced cell uptake, increased cytotoxicity, improved BBB permeability, and demonstrated antitumor efficacy in GBM models.
Article Pharmacology & Pharmacy

Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery

Adenike O. Adekeye, David Needham, Ruman Rahman

Summary: This study determined LDL receptor (LDLR) expression in high grade gliomas (HGGs) using immunohistochemistry and confirmed its potential as a therapeutic target. The study also analyzed LDLR expression levels in three cell line models, confirming their suitability for testing LDLR-targeted nanoparticle uptake, retention, and cytotoxicity.

PHARMACEUTICS (2023)

Article Genetics & Heredity

Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence

Geoffroy Andrieux, Tonmoy Das, Michaela Griffin, Jakob Straehle, Simon M. L. Paine, Juergen Beck, Melanie Boerries, Dieter H. Heiland, Stuart J. Smith, Ruman Rahman, Sajib Chakraborty

Summary: The study investigated the cell population responsible for 5-aminolevulinic acid (5ALA) metabolism and its role in GBM recurrence. The presence of these cells can serve as an early indicator of recurrence and studying their molecular and cellular features can lead to more effective treatments to delay or block GBM recurrence.

GENOME MEDICINE (2023)

Article Materials Science, Biomaterials

Chain-extension in hyperbranched polymers alters tissue distribution and cytotoxicity profiles in orthotopic models of triple negative breast cancers

Cara Moloney, Fatemeh Mehradnia, Robert J. Cavanagh, Asmaa Ibrahim, Amanda K. Pearce, Alison A. Ritchie, Philip Clarke, Ruman Rahman, Anna M. Grabowska, Cameron Alexander

Summary: The therapeutic effectiveness of nanomedicines depends on their access to target sites in the body, which is affected by their size, shape, and transport properties. Designing nanomaterials with optimal physicochemical properties for in vivo efficacy remains a challenge.

BIOMATERIALS SCIENCE (2023)

Article Pharmacology & Pharmacy

Functionalized Block Co-Polymer Pro-Drug Nanoparticles with Anti-Cancer Efficacy in 3D Spheroids and in an Orthotopic Triple Negative Breast Cancer Model

Vincenzo Taresco, Thais F. Abelha, Robert J. Cavanagh, Catherine E. Vasey, Akosua B. Anane-Adjei, Amanda K. Pearce, Patricia F. Monteiro, Keith A. Spriggs, Philip Clarke, Alison Ritchie, Stewart Martin, Ruman Rahman, Anna M. Grabowska, Marianne B. Ashford, Cameron Alexander

Summary: Amphiphilic block co-polymers can assemble into nanoparticles with different sizes and structures, affecting the internalization rate and cytotoxicity towards breast cancer cells, with the BAB blocks accumulating most in the lungs and liver. Nanoparticles generated by conjugating doxorubicin show higher cytotoxicity compared to the free drug.

ADVANCED THERAPEUTICS (2021)

暂无数据